LAV Corporate V GP, Ltd. - Net Worth and Insider Trading
LAV Corporate V GP, Ltd. Net Worth
The estimated net worth of LAV Corporate V GP, Ltd. is at least $220 Million dollars as of 2024-06-22. LAV Corporate V GP, Ltd. is the 2201 Interest of corporation controlled by you of ImmuneOnco Biopharmaceuticals (Shanghai) Inc and owns about 15,178,770 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) stock worth over $220 Million. Details can be seen in LAV Corporate V GP, Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that LAV Corporate V GP, Ltd. has not made any transactions after 2023-09-05 and currently still holds the listed stock(s).
Transaction Summary of LAV Corporate V GP, Ltd.
LAV Corporate V GP, Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, LAV Corporate V GP, Ltd. owns 1 companies in total, including ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) .
Click here to see the complete history of LAV Corporate V GP, Ltd.’s form 4 insider trades.
Insider Ownership Summary of LAV Corporate V GP, Ltd.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:01541 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc | 2023-09-05 | 2201 Interest of corporation controlled by you |
LAV Corporate V GP, Ltd. Latest Holdings Summary
LAV Corporate V GP, Ltd. currently owns a total of 1 stock. LAV Corporate V GP, Ltd. owns 15,178,770 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) as of September 5, 2023, with a value of $220 Million.
Latest Holdings of LAV Corporate V GP, Ltd.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:01541 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc | 2023-09-05 | 15,178,770 | 14.48 | 219,788,590 |
Holding Weightings of LAV Corporate V GP, Ltd.
LAV Corporate V GP, Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, LAV Corporate V GP, Ltd. has made a total of 1 transactions in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in ImmuneOnco Biopharmaceuticals (Shanghai) Inc is the sale of 15,178,770 shares on September 5, 2023, which brought LAV Corporate V GP, Ltd. around $0.
Insider Trading History of LAV Corporate V GP, Ltd.
- 1
LAV Corporate V GP, Ltd. Trading Performance
LAV Corporate V GP, Ltd. Ownership Network
Ownership Network List of LAV Corporate V GP, Ltd.
Ownership Network Relation of LAV Corporate V GP, Ltd.
LAV Corporate V GP, Ltd. Owned Company Details
What does ImmuneOnco Biopharmaceuticals (Shanghai) Inc do?
Who are the key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc?
LAV Corporate V GP, Ltd. is the 2201 Interest of corporation controlled by you of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Other key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc include Ho Yao , CHENG YIQUAN , and 2102 Investment manager LAV Asset Management (Hong Kong) Limited .
ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) Insider Trades Summary
Over the past 18 months, LAV Corporate V GP, Ltd. made 1 insider transaction in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) with a net sale of 0. Other recent insider transactions involving ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) include a net sale of 0 shares made by Greater Bay Area Homeland Investments Limited , a net sale of 0 shares made by Shi Yi , and a net sale of 0 shares made by Tian Wenzhi .
In summary, during the past 3 months, insiders sold 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541)'s detailed insider trading history can be found in Insider Trading Tracker table.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Insider Transactions
LAV Corporate V GP, Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for LAV Corporate V GP, Ltd.. Currently GuruFocus does not have mailing address information for LAV Corporate V GP, Ltd..